Uloric is a prescription medicine used for the treatment of gout and manufactured by a company called Takeda Pharmaceuticals. This medicine has been on the market since 2009. But in February of 2019, the Food and Drug Administration (FDA) published a safety warning concerning the drug, as a clinical trial found an increased risk of heart-related deaths in those who took Uloric compared to the users of another similar medication.
Uloric was on the market for a decade before the FDA issued their black box warning and limited the use of the drug to those who had experienced severe side effects when taking alternative gout drugs. However, questions about the drug's safety were around long before February of 2019.
Learn more about the Uloric Lawsuit: https://theproductlawyers.com/uloric-lawsuit/tv-commercial/
In 2011, former Takeda contractor Dr. Helen Ge filed a whistleblower lawsuit against Takeda, alleging that the pharmaceutical company had hidden serious health risks associated with Uloric and two heartburn drugs called Prevacid and Dexilant.
According to this whistleblower lawsuit, Takeda was aware of Uloric causing kidney problems for patients but kept this information a secret. Dr. Ge also alleged that Takeda had concealed reports of fatal health issues caused by taking Uloric with autoimmune treatments, as well as severe bleeding brought on by taking the drug with a blood thinner called warfarin.
Furthermore, the lawsuit alleges that Takeda knew that the use of Uloric could be fatal when taken with methadone or Imuran.
The complaint goes on to allege that Takeda failed to put information about these dangerous interactions and health risks on warning labels for the drugs. Furthermore, Ge accused the company of failing to report these serious side effects to the FDA.
In the lawsuit, Ge claimed that she was fired after she voiced her concerns to Takeda and suggested that they report these side effects to the FDA and edit the warning labels for the drugs.
This lawsuit was dismissed in 2012 and an appeal was denied in 2014. However, the U.S. Department of Justice was against that dismissal.
Our attorneys expect that Uloric will face significant legal action from families affected by heart attacks, strokes, and other heart issues suffered while taking the drug. The first Uloric lawsuits have already been filed, and more victims will likely file lawsuits as Uloric users and their families begin to realize that the drug may have been responsible for the heart attacks and deaths of their loved ones.
If you or a loved one has suffered a heart attack while taking Uloric, the product lawyers want to help your family find justice. We specialize in lawsuits against negligent pharmaceutical manufacturers or disregard the safety of their customers in order to protect their own profits.
You can learn more about your family's legal options by contacting our attorneys today for a free consultation.